Bayer: 5-year results confirm Essure’s safety and effectiveness
Conceptus Inc.
Olympus sold ‘superbug’ scopes without FDA clearance | Regulatory news for the week of March 9, 2015
Petition accuses Bayer’s Conceptus of altering Essure trial data
UPDATED March 10, 2015, with comment from Bayer.
Exclusive: Bionics maker BiOM taps Charles Carignan for CEO role
BiOM has named Dr. Charles Carignan as its next CEO, replacing Tim McCarthy, who left the company this past spring.
Carignan is a 20-year medtech veteran who has held several key positions in the medical device industry, including most recently at NinePoint Medical, where he was the founder and CEO.
Anti-Essure movement grows online as women slam Bayer’s implant | MassDevice.com On Call
MASSDEVICE ON CALL — The anti-Essure movement, launched by women who claim the permanent contraceptive implant left them with severe pain and injuries, doesn’t look likely to die down, having spawned Facebook support pages, Twitter campaigns and lots of media attention.
The movement has attached itself to the Twitter hashtag ‘#EssureRally’, through which women are calling on Bayer to recall the device, posting pictures of the ralliers in action and organizing real-world events, including street-corner picketing and conference calls with famed consumer advocate Erin Brockovich.
Medtech analyst chides Erin Brockovich’s crusade against Bayer’s birth control implant
FDA responds to patient uprising over Bayer’s Essure birth control implant
The real Erin Brockovich takes on Bayer’s birth control | MassDevice.com On Call
Accuray CFO resigns, new CFO comes from Conceptus
Bayer and Conceptus consummate a $1.1B merger
MassDevice.com +3 | The top 3 med-tech stories for April 29, 2013
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
